Objective 12: Define Inflammatory Bowel Disease (IBD), Explain the Pathological Changes That Occur in the Gastrointestinal Tract, and Identify the Common Risk Factors Associated With Its Development

Inflammatory Bowel Disease (IBD)

A group of chronic inflammatory disorders of the GI tract that includes Crohn disease and ulcerative colitis.

Crohn Disease

A chronic granulomatous inflammatory disorder that can affect any portion of the GI tract and involves transmural inflammation.

Ulcerative Colitis

A chronic inflammatory disorder limited to the colon that begins in the rectum and spreads continuously.

IBD Flare-Up (Relapse)

A period when intestinal inflammation becomes active and symptoms worsen.

IBD Remission

A period when disease activity and symptoms decrease or disappear.

Chronic Intestinal Inflammation

Persistent inflammatory activity that damages GI tissue and interferes with normal intestinal functioning.

Transmural Inflammation

Inflammation involving the entire thickness of the intestinal wall.

Mucosal Inflammation

Inflammation primarily involving the innermost lining of the intestine.

Submucosal Inflammation

Inflammation involving the connective tissue layer directly beneath the mucosa.

Granulomatous Inflammation

An inflammatory pattern associated with Crohn disease that can involve the entire intestinal wall.

Skip Lesions

Patchy areas of intestinal inflammation separated by sections of normal tissue, characteristic of Crohn disease.

Continuous Inflammation

Inflammation that spreads without normal unaffected sections between diseased areas, characteristic of ulcerative colitis.

Fibrosis

Formation of scar tissue within the intestinal wall due to chronic inflammation and tissue injury.

Stricture

Abnormal narrowing of the intestinal lumen caused by inflammation and fibrosis.

Fistula

An abnormal tunnel connecting two organs or different portions of the GI tract.

Abscess

A localized collection of pus caused by infection and inflammation.

Crypts

Intestinal glands located at the base of the mucosa where ulcerative colitis inflammation begins.

Crypt Abscess

An accumulation of inflammatory cells within intestinal crypts.

Ulceration

Breakdown and loss of the intestinal mucosal lining caused by inflammatory tissue injury.

Genetic Susceptibility

Inherited factors that increase an individual's likelihood of developing abnormal intestinal inflammation.

Familial Clustering

The occurrence of a disease more frequently among members of certain families, suggesting genetic susceptibility.

Extraintestinal Manifestations

Complications of IBD that affect organs outside the gastrointestinal tract.

Uveitis

Inflammation involving the uveal structures of the eye; an extraintestinal complication of ulcerative colitis.

Ankylosing Spondylitis

An inflammatory disorder affecting the spine that can occur as an extraintestinal complication of IBD.

IBD Complications

Long-term consequences of chronic inflammation, including strictures, fistulas, abscesses, bleeding, perforation, and colorectal cancer.

What is inflammatory bowel disease?

A group of chronic inflammatory disorders affecting the GI tract, primarily Crohn disease and ulcerative colitis.

What are the two major forms of IBD?

Crohn disease and ulcerative colitis.

What characterizes the disease course of IBD?

Periods of active inflammation called flare-ups or relapses alternating with periods of reduced symptoms called remission.

What happens during an IBD flare-up?

Intestinal inflammation becomes active and symptoms worsen.

What happens during IBD remission?

Disease activity and symptoms decrease or disappear.

What pathological changes occur with IBD?

Chronic inflammation causes cellular injury, swelling, ulceration, and structural changes to the intestinal wall.

How can chronic IBD affect intestinal functioning?

It can interfere with digestion, nutrient absorption, motility, and the protective function of the mucosa.

What is transmural inflammation?

Inflammation that extends through the entire thickness of the intestinal wall.

Which type of IBD is characterized by transmural inflammation?

Crohn disease.

What are skip lesions?

Patchy areas of diseased intestine separated by sections of normal tissue.

Which type of IBD is characterized by skip lesions?

Crohn disease.

What is the pattern of inflammation in ulcerative colitis?

Continuous inflammation that begins in the rectum and spreads proximally through the colon.

Which layers are primarily affected in ulcerative colitis?

The mucosal and submucosal layers.

What are intestinal crypts?

Glands located at the base of the intestinal mucosa.

What are crypt abscesses?

Accumulations of inflammatory cells within intestinal crypts.

What is fibrosis?

The formation of scar tissue within the intestinal wall following chronic inflammation.

How can fibrosis affect the intestine?

It thickens the intestinal wall, reduces flexibility, and can narrow the intestinal lumen.

What is a stricture?

An abnormal narrowing of the bowel that can interfere with intestinal passage.

What is a fistula?

An abnormal tunnel connecting two organs or different portions of the GI tract.

What is an abscess?

A localized collection of pus caused by infection and inflammation.

What are common risk factors associated with IBD development?

Genetic susceptibility and familial clustering.

What does familial clustering suggest about IBD?

Inherited genetic factors may increase susceptibility to abnormal intestinal inflammation.

Does having a family history guarantee that someone will develop IBD?

No. Familial clustering indicates increased susceptibility, not certainty.

What are examples of extraintestinal manifestations of ulcerative colitis?

Arthritis, ankylosing spondylitis, and uveitis.

What long-term complications can result from IBD?

Strictures, fistulas, abscesses, bleeding, perforation, and increased colorectal cancer risk.

How does IBS differ from IBD?

IBS is a functional disorder without structural abnormalities, while IBD causes actual chronic inflammation and intestinal tissue damage.